Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration
- 1 January 1998
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 36 (1), 31-40
- https://doi.org/10.1023/a:1005756023082
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Neurotrophin‐3 reverses experimental cisplatin‐induced peripheral sensory neuropathyAnnals of Neurology, 1995
- Retinoic Acid-Mediated Increase in TrkA Expression Is Sufficient to Elicit NGF-Dependent Survival of Sympathetic NeuronsMolecular and Cellular Neuroscience, 1995
- Effect of cisplatin and ACTH4–9 on neural transport in cisplatin induced neurotoxicityBrain Research, 1995
- Retinoic acid induces BDNF responsiveness of sympathetic neurons by alteration of Trk neurotrophin receptor expressionFEBS Letters, 1994
- Tissue platinum concentrations and cisplatin schedulesThe Lancet, 1990
- Cisplatin NeurotoxicityThe New England Journal of Medicine, 1990
- Efficacy of the neuropeptide ORG.2766 in the prevention and treatment of cisplatin-induced neurotoxicity in ratsEuropean Journal of Cancer and Clinical Oncology, 1988
- Retinoic acid increases the expression of NGF gene in mouse L cellsBiochemical and Biophysical Research Communications, 1987
- Chemical reactivity of cisplatin bound to human plasma proteinsCancer Chemotherapy and Pharmacology, 1987
- Inhibitory effects of anti‐tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in vitroInternational Journal of Cancer, 1970